International Diabetes Federation. IDF diabetes atlas. 9th ed. Brussels, Belgium: International Diabetes Federation; 2019.
Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383(9922):1068–83.
Norris SL, Kansagara D, Bougatsos C, Nygren P, Fu R. Screening for type 2 diabetes mellitus: update of 2003 systematic evidence review for the U.S. Preventive Services Task Force. AHRQ Publication No. 08-05116-EF-1, pp. 1–47; 2008.
Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res. 2005;36:197–209.
Wagner R, Thorand B, Osterhoff MA, Muller G, Bohm A, Meisinger C, et al. Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research. Diabetologia. 2013;56(10):2176–80.
Ahlqvist E, Ahluwalia TS, Groop L. Genetics of type 2 diabetes. Clin Chem. 2011;57(2):241–54.
Hariri S, Yoon PW, Moonesinghe R, Valdez R, Khoury MJ. Evaluation of family history as a risk factor and screening tool for detecting undiagnosed diabetes in a nationally representative survey population. Genet Med. 2006;8:752–9.
Muktabhant B, Sanchaisuriya P, Trakulwong M, Mingchai R, Schelp FP. A first degree relative with diabetes mellitus is an important risk factor for rural Thai villagers to develop type 2 diabetes mellitus. Asia Pac J Public Health. 2015;27(4):385–93.
Kumar A, Tewari P, Sahoo SS, Srivastava AK. Prevalence of insulin resistance in first degree relatives of Type-2 Diabetes mellitus patients: a prospective study in north India population. Indian J Clin Biochem. 2005;20(2):10–7.
Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371(23):2237–8.
Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293–302.
Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999;104:787–94.
Osei K, Rhinesmith S, Gaillard T, Schuster D. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care. 2004;27:1439–46.
Sathiyapriya V, Bobby Z, Agrawal A, Selvaraj N. Protein glycation, insulin sensitivity and pancreatic beta-cell function in high-risk, non-diabetic, first-degree relatives of patients with type 2 diabetes. Indian J Physiol Pharmacol. 2009;53(2):163–8.
Usgaokari AP, Dhume CY, Amonkar SD. Comparative assessment of insulin sensitivity and pancreatic beta cell function in diabetics and non-diabetics. Int J Pharma Bio Sci. 2012;3(1):405–13.
Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA. 1995;273:1855–61.
Bonadonna RC, Stumvoll M, Fritsche A, Muggeo M, Haring H, Bonora E, et al. Altered homeostatic adaptation of first and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. Diabetes. 2003;52:470–80.
Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Matsuura T, et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism. 2004;53:831–5.
Rhee SY, Kwon MK, Park BJ, Chon S, Jeong IK, Oh S, et al. Differences in insulin sensitivity and secretory capacity based on OGTT in subjects with impaired glucose regulation. Korean J Intern Med. 2007;22:270–4.
Liu J, Li YB, Shao H, Li YX, Yuan YH, Xiao YB, et al. Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus. Zhonghua Yi Xue Za Zhi. 2007;15:1252–5.
Qian L, Xu L, Wang X, Fu X, Gu Y, Lin F, et al. Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose regulation. Diabetes Metab Res Rev. 2009;25:144–9.
Han XY, Ji LN, Zhou XH. Cross-sectional study of the pathophysiologic and clinical features in the first-degree relatives of type 2 diabetic patients. Beijing Da Xue Xue Bao. 2005;37:159–62.
Mohammed M, AL-Habori M, Abdullateef A, Saif-Ali R. Impact of metabolic syndrome factors on testosterone and SHBG in type 2 diabetes mellitus and metabolic syndrome. J Diabetes Res. 2018;2018:4926789.
Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12(6):295–300.
Makbul Aman A, Rasyid H, Bakri S, Patellongi IJ. The association between parents history of Type 2 diabetes with metabolic syndrome component and insulin resistance in non-diabetic young adult male. Acta Med Indones. 2018;50(4):309–13.
Bi C, Wang L, Sun C, Sun M, Zheng P, Xue Z, et al. Association between normal triglyceride and insulin resistance in US adults without other risk factors: a cross-sectional study from the US National Health and Nutrition Examination Survey, 2007–2014. BMJ Open. 2019;9:e028652.
Zhao J, Zhang Y, Wei F, Song J, Cao Z, Chen C, et al. Triglyceride is an independent predictor of type 2 diabetes among middle-aged and older adults: a prospective study with 8-year follow-ups in two cohorts. J Transl Med. 2019;17:403.
Cheng Y-H, Tsao Y-C, Tzeng I-S, Chuang H-H, Li W-C, Tung T-H, et al. Body mass index and waist circumference are better predictors of insulin resistance than total body fat percentage in middle-aged and elderly Taiwanese. Medicine. 2017;96(39):e8126.
Fu S, Lin Y, Ping P, Luo L, Ye P. Overall obesity had similar ability to identify the insulin resistance and pancreatic β-cell function compared with abdominal obesity in Chinese community-dwelling population without type 2 diabetes. Int J Clin Exp Med. 2017;10(3):5293–9.
Jeong SU, Kang DG, Lee DH, Lee KW, Lim DM, Kim BJ, et al. Clinical characteristics of Type 2 Diabetes patients according to family history of diabetes. Korean Diabetes J. 2010;34:222–8.
Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T, Tripolino C, et al. Markers of insulin resistance and carotid atherosclerosis: a comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67:665–72.
Moro E, Gallina P, Pais M, Cazzolato G, Alessandrini P, Bittolo-Bon G. Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with the 1999 World Health Organization criteria for the classification of diabetes. Metabolism. 2003;52(5):616–9.
Ginsberg HN, Zhang Y-L, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36(3):232–40.
Riediger ND, Clark K, Lukianchuk V, Roulette J, Bruce S. Fasting triglycerides as a predictor of incident diabetes, insulin resistance and β-cell function in a Canadian First Nation. Int J Circumpolar Health. 2017;76(1):1310444.
Olafsdottir E, Aspelund T, Sigurdsson G, Thorsson B, Benediktsson R, Harris TB, et al. Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons: from the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-Reykjavik). Eur J Epidemiol. 2009;24(6):307–14.
González-Jiménez E, Schmidt-RioValle J, Montero-Alonso MA, Padez C, Garcia-Garcia CJ, Perona JS. Influence of biochemical and anthropometric factors on the presence of insulin resistance in adolescents. Biol Res Nurs. 2016;18:541–8.
Wahrenberg H, Hertel K, Leijonhufvud BM, Persson L-G, Toft E, Amer P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ. 2005;330:1363–4.
Sasaki R, Yano Y, Yasuma T, Onishi Y, Suzuki T, Maruyama-Furuta N, et al. Association of waist circumference and body fat weight with insulin resistance in male subjects with normal body mass index and normal glucose tolerance. Intern Med. 2016;55:1425–32.
Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS One. 2016;11:e0149731.
Zheng S, Shi S, Ren X, Han T, Li Y, Chen Y, et al. Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study. J Transl Med. 2016;14:260.
Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007–2010 Korean National Health and Nutrition Examination Survey. PLoS One. 2019;14(3):e0212963.
Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Investig. 2002;32(S3):14–23.
Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol. 2013;4:71.
Nagle CA, Klett EL, Coleman RA. Hepatic triacylglycerol accumulation and insulin resistance. J Lipid Res. 2009;50:S74–9.
Parhofer KG. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Diabetes Metab J. 2015;39(5):353e62.
Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126(1):12–22.
Zhou YP, Berggren PO, Grill V. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Diabetes. 1996;45(5):580–6.
Bardini G, Rotella CM, Giannini S. Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and beta-cell dysfunction on micro- and macrovascular complications. Rev Diabetes Stud. 2012;9:82–93.
Zheng T, Gao Y, Tian H. Relationship between blood lipid profiles and pancreatic islet beta cell function in Chinese men and women with normal glucose tolerance: a cross sectional study. BMC Public Health. 2012;12:634.
Zheng S, Xu H, Zhou H, Ren X, Han T, Chen Y, et al. Associations of lipid profiles with insulin resistance and β cell function in adults with normal glucose tolerance and different categories of impaired glucose regulation. PLoS One. 2017;12(2):e0172221.
Bardini G, Dicembrini I, Pala L, Cresci B, Rotella CM. Hypertriglyceridaemic waist phenotype and beta-cell function in subjects with normal and impaired glucose tolerance. Diabet Med. 2011;28:1229–33.
Torres-Rasgado E, Porchia LM, Ruiz-Vivanco G, Gonzalez-Mejia ME, Báez-Duarte BG, Pulido-Pérez P, et al. Obese first-degree relatives of patients with type 2 diabetes with elevated triglyceride levels exhibit increased β-cell function. Metab Syndr Relat Disord. 2015;13(1):45–51.
Zheng S, Zhou H, Han T, Li Y, Zhang Y, Liu W, et al. Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride. BMC Endocr Disord. 2015;15:21.
Brunisholz KD, Joy EA, Hashibe M, Gren LH, Savitz LA, Hamilton S, et al. Incidental risk of type 2 diabetes mellitus among patients with confirmed and unconfirmed prediabetes. PLoS One. 2016;11(7):e0157729.
Praveen EP, Sahoo J, Khurana ML, Kulshreshtha B, Khadgawat R, Gupta N, et al. Insulin sensitivity and beta-cell function in normoglycemic offspring of individuals with type 2 diabetes mellitus: impact of line of inheritance. Indian J Endocrinol Metab. 2012;16(1):105–11.
Sharma VK, Nandeesha H, Vinod KV, Subramanian SK, Sankar DS, Rajendran R. Comparison of anthropometric, cardiovascular, autonomic, baroreflex sensitivity, aerobic fitness, inflammatory markers and oxidative stress parameters between first degree relatives of diabetes and controls. Diabetes Metab Syndr Clin Res Rev. 2019;13(1):652–8.
Hulman A, Simmons RK, Brunner EJ, Witte DR, Faerch K, Vistisen D, et al. Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study. Diabetologia. 2017;60:1252–60.
Cai X, Xia L, Pan Y, He D, Zhu H, Wei T, et al. Differential role of insulin resistance and β-cell function in the development of prediabetes and diabetes in middle-aged and elderly Chinese population. Diabetol Metab Syndr. 2019;11:24.
Wang T, Zhao Z, Xu Y, Qi L, Xu M, Lu J, et al. Insulin resistance and β-Cell dysfunction in relation to cardiometabolic risk patterns. J Clin Endocrinol Metab. 2018;103(6):2207–15.
Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab. 2003;88(5):2300–8.
Funakoshi S, Fujimoto S, Hamasaki A, Fujiwara H, Fujita Y, Ikeda K, et al. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Res Clin Pract. 2008;82(3):353–8.
Sun M, Huang X, Jiang L, Yan Y, Li B, Zhong W, et al. Characterization of b-cell function and insulin resistance in overweight Chinese adolescents with normal glucose tolerance. Exp Ther Med. 2013;6(2):547–51.
Cnop M, Schraw T, Vidal J, Scherer PE, Hull RL, Boyko EJ, et al. Progressive loss of β-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with Type 2 Diabetes. Diabetes Care. 2007;30:677–82.
Wang C, Tan H, Yu H, Zhang X, Suo L, Lu Z, et al. Impairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patients. Diabetes Res Clin Pract. 2011;91:67–71.
Morimoto A, Tatsumi Y, Deura K, Mizuno S, Ohno Y, Miyamatsu N, et al. Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku Study. Diabetologia. 2013;56(8):1671–9.
Gastaldelli A, Gaggini M, DeFronzo RA. Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio metabolism study. Diabetes. 2017;66:815–22.
Costa A, Rios M, Casamitjana R, Conget I. High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients: a study in Catalonia, a Mediterranean community. Diabetes Res Clin Pract. 1998;41(3):191–6.
Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes. 2000;49:2094–101.
Pontiroli AE, Monti LD, Costa S, Sandoli PE, Pizzini A, Solerte SB. In middle-aged siblings of patients with type 2 diabetes mellitus normal glucose tolerance is associated with insulin resistance and with increased insulin secretion: the SPIDER Study. Eur J Endocrinol. 2000;143:681–6.
Tripathi D, Carlsson M, Isomaa B. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia study. Diabetes. 2000;49:975–80.
Axelsen M, Smith U, Eriksson JW, Taskinen MR, Jansson PA. Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes. Ann Intern Med. 1999;131(1):27–31.
Cederberg H, Stancakova A, Kuusisto J, Laakso M, Smith U. Family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage? J Intern Med. 2015;277(5):540–51.
Moon JH, Roh E, Oh TJ, Kim KM, Moon JH, Lim S, et al. Increased risk of metabolic disorders in healthy young adults with family history of diabetes: from the Korea National Health and Nutrition Survey. Diabetol Metab Syndr. 2017;9:16.
Chen GW, Li L, Dai F, Li XJ, Xu XX, Fan JG. Prevalence of and risk factors for Type 2 diabetes mellitus in hyperlipidemia in China. Med Sci Monitor. 2015;21:2476–84.
Lee Y-H, Shin M-H, Nam H-S, Park K-S, Choi S-W, Ryu S-W, et al. Effect of family history of diabetes on haemoglobin A1c levels among individuals with and without diabetes. The Dong-gu Study. Yonsei Med J. 2018;59(1):92–100.
Sung KC, Rhee EJ. Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults. Diabet Med. 2007;24:848–54.
Dagogo-Jack S. Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum. Nat Rev Endocrinol. 2010;6:589–93.
Mohan V, Vijayachandrika V, Gokulakrishnan K, Anjana RM, Ganesan A, Weber MB, et al. A1C cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care. 2010;33:515–9.
Osei K, Rhinesmith S, Gaillard T, Schuster D. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in non-diabetic, first-degree relatives of African-American patients with type 2 diabetes? J Clin Endocrinol Metab. 2003;88:4596–601.
Leite SA, Anderson RL, Kendall DM, Monk AM, Bergenstal RM. A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project. Diabetol Metab Syndr. 2009;1:5.
Selvin E, Steffes MW, Zhu H, Anjana RM, Ganesan A, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in non-diabetic adults. N Engl J Med. 2010;362:800–11.
Bonora E, Targher G, Kiechl S, Bonadonna RC, Mayr A, Willeit J, et al. High-normal HbA1c is a strong predictor of type 2 diabetes in the general population. Diabetes Care. 2011;34:1038–40.